Medicine Monash Health, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3800, Australia; Department of Health Sciences, Swinburne University, Melbourne, Australia; Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Australia; Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
Disability and Health Unit, Centre for Health Equity, The Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Mult Scler Relat Disord. 2021 Nov;56:103289. doi: 10.1016/j.msard.2021.103289. Epub 2021 Sep 28.
Introduction Smoking is a key modifiable risk factor in multiple sclerosis (MS). MS healthcare providers have a central role informing people of the deleterious effects of smoking on MS progression and promote smoking cessation, yet there is limited information about smoking cessation and support provided by these providers. This study aimed to gain an understanding of MS healthcare providers current practices, barriers and facilitators related to providing smoking cessation support for people with MS. Methods A total of 13 MS nurses and 6 neurologists working in public and private MS clinics across Australia were recruited through professional networks and MS organisations. Telephone interviews were conducted, transcribed and evaluated using framework analysis. Results MS nurses and neurologists reported that they routinely assess smoking status of people with MS at initial appointments and less regularly also at follow-up appointments. Clinicians considered it important to provide information about smoking impact on MS health outcomes and advise to cease smoking, but the content and delivery varies. Beyond this, some clinicians offer referral for smoking cessation support, while others stated this was not their responsibility, especially in light of competing priorities. Many were unsure about referral pathways and options, requiring more information, training and resources. Conclusion Results of this research indicate that there is potential to improve support for MS clinicians to promote smoking cessation among people with MS. Smoking cessation support may include tailored patient resources, clinician training and stronger collaboration with smoking cessation service providers.
吸烟是多发性硬化症（MS）的一个重要可改变风险因素。MS 医疗保健提供者在告知人们吸烟对 MS 进展的有害影响并促进戒烟方面发挥着核心作用，但关于这些提供者提供的戒烟支持的信息有限。本研究旨在了解 MS 医疗保健提供者在为 MS 患者提供戒烟支持方面的当前做法、障碍和促进因素。
通过专业网络和 MS 组织，共招募了 13 名 MS 护士和 6 名在澳大利亚公立和私立 MS 诊所工作的神经科医生。通过电话访谈进行了研究，将访谈内容转录并使用框架分析法进行评估。
MS 护士和神经科医生报告说，他们在初次就诊时会常规评估 MS 患者的吸烟状况，而在随访就诊时则不太经常评估。临床医生认为提供有关吸烟对 MS 健康结果影响的信息并建议戒烟很重要，但内容和方法因人而异。除此之外，一些临床医生会提供戒烟支持的转介，而另一些则表示这不是他们的责任，尤其是在面临竞争优先级的情况下。许多人对转介途径和选择不确定，需要更多的信息、培训和资源。
这项研究的结果表明，有可能改善对 MS 临床医生的支持，以促进 MS 患者戒烟。戒烟支持可能包括针对患者的资源、临床医生培训以及与戒烟服务提供者的更紧密合作。
